The Healthcare News Diaries
Novo CEO pressed by Senate to cut selling prices of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would contemplate new talks with insurers regarding the record rates of Wegovy and copyright should they pledge to keep the medicines on their formularies.Since some electronic overall health star